Cargando…
Radiolabelled Peptides for Positron Emission Tomography and Endoradiotherapy in Oncology †
This review deals with the development of peptide-based radiopharmaceuticals for the use with positron emission tomography and peptide receptor radiotherapy. It discusses the pros and cons of this class of radiopharmaceuticals as well as the different labelling strategies, and summarises approaches...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169460/ https://www.ncbi.nlm.nih.gov/pubmed/32019275 http://dx.doi.org/10.3390/ph13020022 |